TECOS

A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (TECOS)

Stadium: klaar
Middel: Sitagliptin
Populatie: ASCVD
Fase: III
First Patient In: 15 november 2008
Last Patient In: 1 mei 2012
Last Patient Last Visit: -

Studiedirecteur

prof. dr. J.H. Cornel

Cardioloog